![](/imgs/covers/mj_cover.jpg)
|
Malaysian Journal of Medical Sciences
School of Medical Sciences, Universiti Sains Malaysia
ISSN: 1394-195X
Vol. 10, No. 2, 2003, pp. 27-30
|
Bioline Code: mj03019
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Malaysian Journal of Medical Sciences, Vol. 10, No. 2, 2003, pp. 27-30
en |
REVIEW ARTICLE - Management of Diabetic Neuropathy
Raymond Azman Ali
Abstract
Diabetes mellitus is the commonest cause of neuropathy worldwide. Diabetic neuropathy (DN) develops in about 4-10% of diabetic patients after 5 years and in 15% after 20 years.Four main mechanisms have been postulated to underlie the pathogenesis of DN. Diabetic neuropathy can be divided into symmetrical and asymmetrical neuropathies. Diabetic Autonomic Neuropathy (DAN) parallels the severity of DSN, and affects primarily the cardiovascular, gastrointestinal, genitourinary and integumentary systems. The cornerstone of treatment of diabetic neuropathy is optimization of glycaemic control. Future treatments for diabetic neuropathy should address the underlying pathogenesis.
Keywords
Diabetes Mellitus, Neuropathy, Management
|
|
© Copyright 2003 - Malaysian Journal of Medical Sciences Alternative site location: http://www.medic.usm.my/publication/mjms/
|
|